Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.3600
-0.0165 (-4.38%)
Apr 25, 2025, 11:56 AM EDT - Market open

Entero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
23351829
Upgrade
Market Cap Growth
4.30%4.30%-44.22%-71.77%-38.97%6.51%
Upgrade
Enterprise Value
264-041118
Upgrade
Last Close Price
0.380.624.20122.586069.0140740.04
Upgrade
Debt / Equity Ratio
0.000.000.230.32-0.13-0.24
Upgrade
Quick Ratio
0.010.011.190.590.670.43
Upgrade
Current Ratio
3.033.031.581.370.770.51
Upgrade
Return on Equity (ROE)
-50.87%-50.87%-497.87%---3305.91%
Upgrade
Return on Assets (ROA)
-21.16%-21.16%-159.97%-91.98%-286.81%-151.38%
Upgrade
Return on Capital (ROIC)
-31.30%-31.30%-244.72%---784.82%
Upgrade
Buyback Yield / Dilution
-921.26%-921.26%-836.57%---
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q